Literature DB >> 11806878

Dyslexia and familial high blood pressure: an observational pilot study.

K Taylor1, J Stein.   

Abstract

BACKGROUND: Developmental dyslexia is a neurodevelopmental learning disability characterised by unexpectedly poor reading and unknown aetiology. One hypothesis proposes excessive platelet activating factor, a potent vasodilator, as a contributor, implying that there should be a negative association between dyslexia and high blood pressure (HBP). Since both conditions have a partial genetic basis, this association may be apparent at the familial level. AIMS: To test this prediction in dyslexic and non-dyslexic children.
METHODS: Individuals and families with (HBP+) and without (HBP-) a family history of HBP were compared.
RESULTS: Proportionately fewer dyslexics (49/112) than controls (11/12) were HBP+. Families with multiple, all dyslexic children were less likely to be HBP+ (7/16) than those with a non-dyslexic child (11/11). Within families, mean child scores on reading were higher in the HBP+ group (mean 44.3, SE 0.95) than in the HBP- group (mean 40.3, SE 0.87).
CONCLUSION: HBP+ family history is associated with better performance on reading. The prediction of a negative association between dyslexic status and familial high blood pressure is therefore confirmed.

Entities:  

Mesh:

Year:  2002        PMID: 11806878      PMCID: PMC1719045          DOI: 10.1136/adc.86.1.30

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

1.  Reading disability: evidence for a genetic etiology.

Authors:  J Gayán; R K Olson
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

2.  Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase.

Authors:  W K Bleeker; J L Teeling; A J Verhoeven; G M Rigter; J Agterberg; A T Tool; A H Koenderman; T W Kuijpers; C E Hack
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

3.  Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome.

Authors:  R Wu; C Lemne; U De Faire; J Frostegârd
Journal:  J Intern Med       Date:  1999-10       Impact factor: 8.989

4.  Dyslexia in adults is associated with clinical signs of fatty acid deficiency.

Authors:  K E Taylor; C J Higgins; C M Calvin; J A Hall; T Easton; A M McDaid; A J Richardson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2000 Jul-Aug       Impact factor: 4.006

5.  Hypernatraemic dehydration and breast feeding: a population study.

Authors:  S Oddie; S Richmond; M Coulthard
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

6.  Abnormal cerebral phospholipid metabolism in dyslexia indicated by phosphorus-31 magnetic resonance spectroscopy.

Authors:  A J Richardson; I J Cox; J Sargentoni; B K Puri
Journal:  NMR Biomed       Date:  1997-10       Impact factor: 4.044

Review 7.  Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation.

Authors:  D Stanimirovic; K Satoh
Journal:  Brain Pathol       Date:  2000-01       Impact factor: 6.508

Review 8.  Current perspectives on the use of gene therapy for hypertension.

Authors:  C H Gelband; M J Katovich; M K Raizada
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

9.  Recent trends in hospital use by children in England.

Authors:  R MacFaul; U Werneke
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

10.  Could platelet activating factor play a role in developmental dyslexia?

Authors:  K E Taylor; A J Richardson; J F Stein
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2001-03       Impact factor: 4.006

View more
  1 in total

1.  Identification of candidate genes for dyslexia susceptibility on chromosome 18.

Authors:  Thomas S Scerri; Silvia Paracchini; Andrew Morris; I Laurence MacPhie; Joel Talcott; John Stein; Shelley D Smith; Bruce F Pennington; Richard K Olson; John C DeFries; Anthony P Monaco; Alex J Richardson
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.